Smartleaf Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Smartleaf Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$535K	Hold	846	–	–	0.02%	538
2026 Q1	$635K	Buy	846 +137	+19%	+$105K	0.02%	485
2025 Q4	$549K	Sell	709 -32	-4%	-$21.7K	0.02%	510
2025 Q3	$416K	Buy	741 +188	+34%	+$106K	0.03%	520
2025 Q2	$288K	Sell	553 -307	-36%	-$171K	0.03%	494
2025 Q1	$548K	Sell	860 -92	-10%	-$63.3K	0.05%	340
2024 Q4	$669K	Buy	952 +72	+8%	+$60.4K	0.07%	280
2024 Q3	$918K	Buy	880 +213	+32%	+$237K	0.11%	205
2024 Q2	$701K	Buy	667 +186	+39%	+$180K	0.11%	201
2024 Q1	$465K	Buy	481 +217	+82%	+$206K	0.09%	226
2023 Q4	$233K	Buy	+264	New	+$217K	0.06%	297

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Smartleaf Asset Management's REGN Position: Q2 2026 in Review

Smartleaf Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 846 shares worth $535K. The position accounts for 0.02% of the portfolio, ranked #538.

Smartleaf Asset Management first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $918K in Q3 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Smartleaf Asset Management held 846 shares of Regeneron Pharmaceuticals worth $535K as of Q2 2026.
Smartleaf Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.02% of Smartleaf Asset Management's portfolio in Q2 2026, its #538 holding.
Smartleaf Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Smartleaf Asset Management's Regeneron Pharmaceuticals position peaked at $918K in Q3 2024.
1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.